Medifast Income Statement (2010-2025) | MED

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	340.67M	394.19M	413.39M	377.83M	417.60M	453.33M	390.40M	337.25M	348.98M	296.19M	235.87M	191.01M	174.74M	168.56M	140.16M	119.00M	115.73M	105.56M	89.41M	75.10M
Cost of Revenue (Quarter)	92.12M	100.48M	106.34M	99.55M	115.31M	131.65M	107.55M	103.65M	102.59M	85.47M	58.49M	49.65M	47.45M	45.12M	34.49M	30.78M	31.48M	28.91M	27.25M	22.96M
Gross Profit (Quarter)	248.55M	293.71M	307.06M	278.29M	302.29M	321.68M	282.85M	233.60M	246.39M	210.72M	177.38M	141.37M	127.29M	123.44M	105.67M	88.22M	84.25M	76.64M	62.16M	52.14M
Operating items
Selling, General & Administrative (Quarter)	195.75M	232.27M	251.89M	231.45M	247.20M	272.72M	234.69M	201.00M	192.88M	172.01M	151.87M	132.69M	119.35M	131.31M	103.57M	87.51M	85.51M	77.71M	66.24M	59.94M
Operating Expenses (Quarter)	195.75M	232.27M	251.89M	231.45M	247.20M	272.72M	234.69M	201.00M	192.88M	172.01M	151.87M	132.69M	119.35M	131.31M	103.57M	87.51M	85.51M	77.71M	66.24M	59.94M
Operating Income (Quarter)	52.80M	61.43M	55.17M	46.84M	55.09M	48.96M	48.16M	32.60M	53.51M	38.71M	25.51M	8.68M	7.94M	-7.88M	2.11M	0.71M	-1.26M	-1.07M	-4.08M	-7.80M
EBIT (Quarter)	52.80M	61.43M	55.17M	46.84M	55.09M	48.96M	48.16M	32.60M	53.51M	38.71M	25.51M	8.68M	7.94M	-7.88M	2.11M	0.71M	-1.26M	-1.07M	-4.08M	-7.80M
Non-operating items
Interest & Investment Income (Quarter)	0.02M	-0.07M	-0.09M	-0.09M	-0.10M	-0.16M	-0.26M	-0.18M	-0.18M	0.46M	1.03M	1.18M	1.22M	1.30M	1.33M	0.95M	1.30M	1.37M	1.43M	1.42M
Other Non Operating Income (Quarter)	0.02M	-0.02M	0.12M	0.01M	-0.02M	-0.00M	-0.02M	-0.01M	-0.00M	-0.05M	0.01M	-0.05M	2.42M	-4.07M	-1.86M	-0.39M	0.49M	2.57M	-0.00M	0.00M
Non Operating Income (Quarter)	0.02M	-0.09M	0.02M	-0.09M	-0.11M	-0.17M	-0.02M	-0.71M	-0.00M	-0.05M	1.04M	-0.05M	3.65M	-4.07M	-0.53M	4.42M	1.79M	3.94M	1.42M	5.52M
Net income details
EBT (Quarter)	52.84M	61.34M	55.19M	46.75M	54.98M	48.80M	47.88M	32.41M	53.33M	39.12M	26.55M	9.80M	11.59M	-10.65M	1.58M	1.27M	0.53M	2.88M	-2.66M	-6.38M
Tax Provisions (Quarter)	11.78M	14.38M	13.21M	12.73M	13.20M	9.68M	11.72M	5.89M	13.36M	8.84M	3.42M	3.77M	3.27M	-2.50M	0.45M	0.50M	1.30M	0.40M	-0.40M	11.73M
Profit After Tax (Quarter)	41.06M	46.96M	41.98M	34.02M	41.78M	39.11M	36.16M	26.52M	39.97M	30.28M	23.13M	6.04M	8.32M	-8.15M	1.13M	0.80M	-0.77M	2.48M	-2.26M	-18.12M
Income from Continuing Operations (Quarter)	41.06M	46.96M	41.98M	34.02M	41.78M	39.11M	36.16M	26.52M	39.97M	30.28M	23.13M	6.04M	8.32M	-8.15M	1.13M	0.78M	-0.77M	2.48M	-2.26M	-18.11M
Consolidated Net Income (Quarter)	41.06M	46.96M	41.98M	34.02M	41.78M	39.11M	36.16M	26.52M	39.97M	30.28M	23.13M	6.04M	8.32M	-8.15M	1.13M	0.78M	-0.77M	2.48M	-2.26M	-18.11M
Income towards Parent Company (Quarter)	41.06M	46.96M	41.98M	34.02M	41.78M	39.11M	36.16M	26.52M	39.97M	30.28M	23.13M	6.04M	8.32M	-8.15M	1.13M	0.78M	-0.77M	2.48M	-2.26M	-18.11M
Net Income towards Common Stockholders (Quarter)	41.06M	46.96M	41.98M	34.02M	41.78M	39.11M	36.16M	26.52M	39.97M	30.28M	23.13M	6.04M	8.32M	-8.15M	1.13M	0.78M	-0.77M	2.48M	-2.26M	-18.11M
Additional items
EPS (Basic) (Quarter)	3.49	4.00	3.59	2.94	3.62	3.44	3.30	2.45	3.68	2.78	2.12	0.55	0.76	-0.75	0.10	0.07	-0.07	0.23	-0.21	-1.65
EPS (Weighted Average and Diluted) (Quarter)	3.46	3.96	3.56	2.91	3.59	3.42	3.27	2.43	3.67	2.77	2.12	0.55	0.76	-0.75	0.10	0.07	-0.07	0.22	-0.21	-1.65
Shares Outstanding (Weighted Average) (Quarter)	11.77M	11.76M	11.74M	11.71M	11.56M	11.35M	10.96M	11.20M	10.86M	10.88M	10.89M	10.88M	10.91M	10.94M	10.93M	10.93M	10.95M	10.99M	10.98M	10.98M
Shares Outstanding (Diluted Average) (Quarter)	11.88M	11.86M	11.79M	11.81M	11.64M	11.44M	11.04M	11.28M	10.90M	10.92M	10.93M	10.92M	10.96M	10.97M	10.97M	10.96M	10.95M	11.04M	10.99M	10.98M
EBITDA (Quarter)	52.80M	61.43M	55.17M	46.84M	55.09M	48.96M	48.16M	32.60M	53.51M	38.71M	25.51M	8.68M	7.94M	-7.88M	2.11M	0.71M	-1.26M	-1.07M	-4.08M	-7.80M
Tax Rate (Quarter)	22.29%	23.44%	23.93%	27.23%	24.00%	19.84%	24.49%	18.17%	25.05%	22.59%	12.87%	38.43%	28.22%	23.44%	28.45%	39.22%	247.15%	13.91%	15.05%	-183.85%

Research Tools

Medifast Income Statement (2010-2025) | MED

Create an account

Sign In

Reset Password